What Is Anastrozole?
Anastrozole is a selective aromatase inhibitor (AI) that blocks the conversion of testosterone into estrogen. When you're on testosterone replacement therapy, some of that testosterone naturally converts to estrogen through an enzyme called aromatase. Anastrozole shuts down that enzyme, preventing estrogen-related side effects like gynecomastia (breast tissue growth), water retention, and mood swings.
Originally developed as a breast cancer medication under the brand name Arimidex, it's now used off-label in men's hormone optimization. Unlike estrogen blockers that work downstream, anastrozole stops estrogen production at the source.
Most TRT protocols use low doses — 0.25-0.5mg taken 2-3 times per week. That's roughly a quarter of the FDA-approved dose for cancer treatment. The goal isn't to eliminate estrogen completely — you need some estrogen for bone health, libido, and brain function — but to keep it in a healthy range.
Clinical positioning: Anastrozole is the most prescribed AI in TRT, valued for its predictable dose-response curve and reversibility if estrogen drops too low.
Anastrozole at a Glance
Class: Non-steroidal aromatase inhibitor
Brand Names: Arimidex
DEA Schedule: None (not a controlled substance)
Administration: Oral tablet, 2-3 times per week
Half-Life: 46 hours
Typical Cost: $15-40/month (generic), $5-15/month effective cost at TRT doses
FDA Approved for TRT: No (off-label use; approved for breast cancer)
Monitoring: Estradiol (sensitive assay) every 3-6 months, lipid panel annually
Onset: Symptom relief in 3-7 days, full lab effect in 10-14 days
Fertility Impact: Neutral (may slightly improve fertility by optimizing estrogen-to-testosterone ratio)
How Anastrozole Works
Anastrozole competitively inhibits the aromatase enzyme (CYP19A1), which converts androgens into estrogens in fat tissue, the liver, and the adrenal glands1. When you inject or apply testosterone, a percentage of it converts to estradiol — the primary estrogen in males. Anastrozole binds to the aromatase enzyme's active site, blocking that conversion without affecting testosterone production itself.
The drug works fast. With a 46-hour half-life, anastrozole reaches steady-state blood levels within 7-10 days2. Most men notice symptom relief within a week — the bloating drops, the emotional volatility smooths out, and nipple sensitivity resolves.
But here's the critical nuance: anastrozole doesn't reduce existing estrogen. It only prevents new estrogen formation. If your estradiol is already elevated, you'll see levels decline gradually as your body clears the existing estrogen. That's why lab work typically shows the full effect after 10-14 days on a stable dose.
Compared to other aromatase inhibitors, anastrozole sits in the middle. Exemestane (Aromasin) is a steroidal AI that permanently deactivates aromatase, while letrozole (Femara) is more potent but harder to dose precisely. Anastrozole's reversible mechanism gives you better control — if you overshoot and crash your estrogen, you can back off the dose and recover within days.
Aromatase is an enzyme (CYP19A1) that catalyzes the conversion of androgens into estrogens in peripheral tissues including fat, liver, and adrenal glands. It is the primary target of aromatase inhibitor drugs like anastrozole.
Estradiol is the most potent and biologically active form of estrogen in the human body. In males, it is produced through aromatization of testosterone and plays a role in bone health, cardiovascular function, and emotional regulation.
Dosing & Administration
Standard oncology dosing is 1mg daily, but that's far too aggressive for TRT. Most clinics start men at 0.25mg twice weekly, then titrate based on lab work. The goal is to keep estradiol in the 20-40 pg/mL range — high enough to protect bones and libido, low enough to prevent water retention and gynecomastia.
Timing matters. Because anastrozole's half-life is about two days, dosing frequency affects stability. Twice-weekly dosing provides smoother estrogen control than once-weekly pulses. Some clinics dose with testosterone injections; others stagger it mid-week. Both work — consistency is what matters.
| Parameter | Standard Protocol | Clinical Notes |
|---|---|---|
| Starting Dose | 0.25mg twice weekly | Take on injection days or fixed schedule |
| Dose Titration | Adjust by 0.125-0.25mg per dose | Wait 3-4 weeks between adjustments |
| Maximum Dose | 0.5mg three times weekly (1.5mg/week total) | Higher doses risk crashing estrogen |
| Initial Lab Check | 4-6 weeks after starting | Check estradiol, total testosterone, SHBG |
| Ongoing Monitoring | Every 3 months for first year | Then every 6 months if stable |
| Target Estradiol Range | 20-40 pg/mL (sensitive assay) | Symptoms trump numbers |
No dose adjustment needed for age, kidney function, or liver disease2. If you miss a dose, don't double up the next day — the drug level stays elevated enough from the previous dose.
Side Effects & Safety
The most common issue isn't side effects from the drug itself — it's crashing your estrogen too low. When estradiol drops below 10-15 pg/mL, you'll notice it fast. Joints ache. Libido disappears. Mood tanks. Erectile quality suffers.
That's why "low and slow" is the mantra. Start with minimal doses and titrate based on labs and symptoms, not guesswork.
| Frequency | Side Effect | Clinical Context |
|---|---|---|
| Common (>10%) | Joint pain, stiffness | Estrogen supports joint lubrication; more common with aggressive dosing |
| Common (>10%) | Headache | Usually mild, often resolves after 2-3 weeks |
| Occasional (1-10%) | Nausea, dizziness | Take with food if this occurs |
| Occasional (1-10%) | Hot flashes | Sign of effective estrogen suppression |
| Rare (<1%) | Bone density loss | Long-term concern with prolonged use; monitor DEXA scans annually |
| Rare (<1%) | Elevated liver enzymes | Check baseline and annual liver function tests |
The lipid profile concern from cancer studies doesn't seem to apply at TRT doses. Research in postmenopausal women showed neutral effects on cholesterol after 12 months1. Still, check a lipid panel every 6-12 months as part of routine TRT monitoring.
Cost & Access
Anastrozole is one of the most affordable AI options. Generic 1mg tablets run $15-40 per month depending on your pharmacy and insurance coverage. Since you're splitting tablets into quarters for TRT dosing, a 30-day supply lasts 3-4 months, bringing the real cost down to $5-15 monthly.
Brand-name Arimidex costs significantly more — $200-300 per month — with no clinical advantage over generic versions. Don't pay for the brand unless your insurance covers it.
Most commercial insurance plans cover anastrozole for FDA-approved indications (breast cancer), but off-label TRT use often requires out-of-pocket payment. Some clinics include it in their monthly TRT package pricing. Telehealth services typically charge $20-50 per month for AI prescriptions plus the medication cost.
Compounded anastrozole is available through specialty pharmacies at similar or slightly lower prices. Some men prefer compounded capsules in precise 0.25mg doses to avoid tablet splitting. Compounding costs $25-50 monthly but saves the hassle of cutting pills.